Unilateral intravitreal dexamethasone implant for diabetic macular edema: effect in the contralateral eye.
Alicia Pareja-RíosSergio Bonaque-GonzálezPublished in: Arquivos brasileiros de oftalmologia (2020)
We describe three patients who had previous heart diseases and nonproliferative diabetic retinopathy with clinically significant diabetic macular edema. They underwent unilateral dexamethasone intravitreal implantation. Without ophthalmological treatment in the fellow eye, patients showed marked bilateral improvement in best-corrected visual acuity, optical coherence images, and macular thickness values. These findings provide evidence of the bilateral effect of dexamethasone intravitreal implantation, which may be clinically useful in patients for whom the systemic effects of the drug may affect their general health.
Keyphrases
- diabetic retinopathy
- optical coherence tomography
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- low dose
- vascular endothelial growth factor
- public health
- peritoneal dialysis
- prognostic factors
- heart failure
- deep learning
- high resolution
- machine learning
- patient reported outcomes
- endothelial cells
- mass spectrometry
- electronic health record
- replacement therapy
- combination therapy
- smoking cessation
- soft tissue